Helen Louise Collins, CMO at Enliven Therapeutics, holds 25.00K shares in Enliven Therapeutics (Ticker: ELVN), holds ― shares in IO Biotech (Ticker: IOBTQ), holds 0.00 shares in Five Prime Therapeutics (Ticker: FPRX).
What is the percentage of profitable transactions made by Helen Louise Collins?
The percentage of profitable transactions made by Helen Louise Collins is ―.
What is the average return per transaction made by Helen Louise Collins?
The average return per transaction made by Helen Louise Collins is ―.
What stocks does Helen Louise Collins hold?
Helen Louise Collins holds: ELVN, IOBTQ, FPRX, KURA stocks.
What was Helen Louise Collins’s latest transaction?
Helen Louise Collins latest transaction was an Uninformative Buy of $12.40K.
What was Helen Louise Collins's most profitable transaction?
Helen Louise Collins’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Helen Louise Collins's role in Enliven Therapeutics?
Helen Louise Collins's role in Enliven Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.